NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI
Conditions: Coronary Artery Disease; Percutaneous Coronary Intervention; Acute Coronary Syndrome Interventions: Drug: Aspirin + Clopidogrel + Rivaroxaban; Drug: Aspirin + Clopidogrel Sponsor: China National Center for Cardiovascular Diseases Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2022 Category: Research Source Type: clinical trials